CAS: 64622-45-3; Pyridin-2-Ylmethyl 2-(4-Isobutylphenyl)Propanoate

该化合物是一种化学化合物,其特性结合了Ibuprofen(一种众所周知的非类动物抗炎药物(NSAID)的特性,一种众所周知的非类动物抗炎药物(NSAID)的特性和一种匹古醇的特性.该化合物的特点是厌食性,抗炎性,抗性传染效应,使其在疼痛,炎症和发烧的治疗中发挥作用.ibuproprofen piconol的结构允许与传统的ibuprofen相比,增加溶性和生物利用率,从而有可能改善治疗结果.该化合物通常在各种配方(包括平板和局部应用)中施用.该化合物的行动机制包括抑制环氧酶酶,它在合成丙草原,止痛和发炎症调节器方面发挥着关键作用.尽管 ibuprofen picol的结构与所有药物一样, 其副作用和抗药性都可确保基本使用药物.

结构式图片

上下游产品

甲基-2 -(4-异丁基苯基)丙酸 (+/-)-Ibuprofen Methyl Ester 61566-34-5

合成工艺路线路线简述

    2-吡啶甲醇,2-(4-异丁基苯基)丙酰氯置于三乙胺体系中,用 四氢呋喃,水 作为反应溶剂,化学反应生成 匹美诺芬
    参考文献:Pyridylalkyl Esters Of 2-(P-Isobutylphenyl)Acetic Acid And Propionic
    标题:Pyridylalkyl Esters Of 2-(P-Isobutylphenyl)Acetic Acid And Propionic
    摘要:本发明涉及以下一般公式的苯乙酸酯衍生物:##str1##其中,R从由较低的烷基(不包括乙基)和取代的较低烷基组成的群体中选择,R'可以是氢或甲基.本发明得到的化合物具有较高的镇痛,退热和抗炎活性,在口服和局部给药时对胃肠道的副作用很小,它们可能作为口服和局部的镇痛剂,退热剂和抗炎剂有用.

    海关参考信息

    专利信息


    专利号:US-2013035307-A1
    优先权日:2010-01-26
    标 题:Methods for treating or preventing the spread of cancer using semi-synthetic glycosaminoglycosan ethers
    发明人:PRESTWICH GLENN D; KENNEDY THOMAS P
    权利人:UNIV UTAH RES FOUND; PRESTWICH GLENN D; KENNEDY THOMAS P
    摘要:Described herein are methods for the treatment and prevention of tumor metastasis using alkylated and fluoroalkylated semi-synthetic glycosaminoglycan ethers (“SAGEsâ€?). The synthesis of sulfated alkylated and fluoroalkylated SAGEs is also described.

    专利号:WO-2023096715-A9
    优先权日:2021-10-22
    标 题:Immunomodulatory glycosphingolipids and methods of use thereof
    发明人:KASPER DENNIS; OH SUNGWHAN
    权利人:HARVARD COLLEGE
    摘要:Provided herein are a subset of alpha-galactosylceramide (alpha-GC) compounds having improved immunomodulatory activity, particularly with respect to NKT cell number and activity. Also provided herein are methods of use of such compounds, including in the modulation of NKT cells and/or activity in vivo. Further provided are combinatorial synthesis methods for generating alpha-GC compounds of specifically defined structure and thereby generating pure preparations thereof.

    专利号:US-4778805-A
    优先权日:1987-06-18
    标题:4,7-benzofurandione derivatives useful as inhibitors of leukotriene synthesis
    发明人:ADAMS JULIAN; GUINDON YVAN; BELANGER PATRICE C; BELLEY MICHEL L; ROKACH JOSHUA
    权利人:MERCK FROSST CANADA
    摘要:4,7-Benzofurandione derivatives of Formula I, pharmaceutical compositions, and methods of treatment are disclosed. These compounds are useful as inhibitors of mammalian leukotriene biosynthesis. As such, these compounds are useful therapeutic agents for treating allergic conditions, asthma, cardiovascular disorders, inflammation, psoriasis and allergic conjunctivitis. The compounds are also useful as analgesics and as cytoprotective agents. Also disclosed are novel intermediates useful for the preparation of the 4,7-benzofurandiones of this invention. ##STR1##

    专利号:US-2022125838-A1
    优先权日:2019-02-11
    标题 :Immunomodulatory glycosphingolipids and methods of use thereof
    发明人:OH SUNGWHAN; KASPER DENNIS L; SONG HEEBUM; PARK SEUNG BUM
    权利人:HARVARD COLLEGE; SEOUL NAT UNIV R&DB FOUNDATION
    摘要:Provided herein are a subset of alpha-galactosylceramide (alpha-GC) compounds having improved immunomodulatory activity, particularly with respect to NKT cell number and activity. Also provided herein are methods of use of such compounds, including in the modulation of NKT cells and/or activity in vivo. Further provided are combinatorial synthesis methods for generating alpha-GC compounds of specifically defined structure and thereby generating pure preparations thereof.

    专利号:US-9907753-B2
    优先权日:2010-03-19
    标 题 :Lipid vesicle compositions and methods of use
    发明人:IRVINE DARRELL J; MOON JAEHYUN
    权利人:MASSACHUSETTS INST TECHNOLOGY
    摘要:The invention provides delivery systems comprised of stabilized multilamellar vesicles, as well as compositions, methods of synthesis, and methods of use thereof. The stabilized multilamellar vesicles may comprise prophylactic, therapeutic and/or diagnostic agents.

    专利号:CN-111455430-B
    优先权日:2020-04-21
    标题 :A method for in-situ synthesis of radial Mg(OH)2 lines on the surface of magnesium-based composites
    安徽星宇化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.pyridinechem.com
    电话:0555-2568883;👤
    📞 安徽星宇化工有限公司⚠️参考联系方式

    电话: 0555-2568883;
    邮件:jvd@pyridinechem.com
    网址: http://www.pyridinechem.com
    地址:安徽和县乌江镇安徽省精细化工园区
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    安徽和县乌江镇安徽省精细化工园区
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Christensen JM, Stalker D. Ibuprofen piconol hydrolysis in vitro in plasma, whole blood, and serum using different anticoagulants. J Pharm Sci. 1991 Jan;80(1):29-31.

    合成参考文献


    摘要:Oyo Yakuri. Pharmacometrics., 23(691), 1982
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知